Get started
Author

Zhijun Cao

ORCID: 0009-0009-6032-4836
Observed ORCID: 0009-0009-6032-4836
OpenAlex ID: A5055984034
Discovery of the First-in-Class Intestinal Restricted FXR and FABP1 Dual Modulator ZLY28 for the Treatment of Nonalcoholic Fatty Liver Disease
2023 · Qiang Ren, Ya Chen, et al. · Journal of Medicinal Chemistry · 30
Discovery of First-in-Class FXR and HSD17B13 Dual Modulator for the Treatment of Metabolic Dysfunction-Associated Fatty Liver Disease
2025 · Shixuan Jiao, Qiang Ren, et al. · Journal of Medicinal Chemistry · 18
Discovery of LH10, a novel fexaramine-based FXR agonist for the treatment of liver disease
2024 · Wanqiu Huang, Zhijun Cao, et al. · Bioorganic Chemistry · 17
Design, synthesis, and biological evaluation of first-in-class FABP1 inhibitors for the treatment of NASH
2024 · Ya Chen, Mingyang Yu, et al. · European Journal of Medicinal Chemistry · 12
Design, synthesis, and biological evaluation studies of novel carboxylesterase 2 inhibitors for the treatment of irinotecan-induced delayed diarrhea
2023 · Zhongcheng Yang, Zhijun Cao, et al. · Bioorganic Chemistry · 8
Discovery of novel carboxylesterase 2 inhibitors for the treatment of delayed diarrhea and ulcerative colitis
2023 · Zhijun Cao, Yuxia Liu, et al. · Biochemical Pharmacology · 6
Discovery of a structurally novel, potent, and once-weekly free fatty acid receptor 1 agonist for the treatment of diabetes
2022 · Bin Wang, Zongyu Cai, et al. · European Journal of Medicinal Chemistry · 6
Discovery of the FXR/CES2 dual modulator LE-77 for the treatment of irinotecan-induced delayed diarrhea
2024 · Zhijun Cao, Wenxin Wang, et al. · Bioorganic Chemistry · 5
Design, synthesis, and biological studies of novel sulfonamide derivatives as farnesoid X receptor agonists
2023 · Wenxin Wang, Zhijun Cao, et al. · European Journal of Medicinal Chemistry · 5
MKI67 with arterial hypertension predict a poor survival for prostate cancer patients, a real-life investigation
2024 · Yongqiang Zhou, Weihai Chen, et al. · Clinical & Translational Oncology · 3
The Transcription Factor CREB1 Triggers the Progression of Clear Cell Renal Cell Carcinoma by Promoting CENPE Expression
2025 · Hao Jiang, Jingyuan Tang, et al. · Journal of Cellular and Molecular Medicine · 2
Design, Synthesis and Biological Activity Evaluation of Novel URAT1 Inhibitors
2022 · Siliang Chen, Ya Chen, et al. · ChemistrySelect · 1
PDF
Works count: 12
Citation count: 113
H-index: 6
I10-index: 4
Year
Topic
Type